XML 37 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2022   13,047    
Beginning Balance at Sep. 30, 2022 $ 92,060 $ 13 $ 91,057 $ 990
Issuance and fair value adjustment of common stock in business combination (in shares)   527    
Issuance and fair value adjustment of common stock in business combination 6,539 $ 1 6,538  
Expense related to director restricted stock units 718   718  
Expense related to director restricted stock unit (shares)   0    
Expense related to employee stock-based compensation 1,204   1,204  
Stock issued for director restricted stock units (in shares)   50    
Stock issued for director restricted stock units 0      
Exercise of stock options (shares)   393    
Exercise of stock options 1,107   1,107  
Common stock surrendered for the exercise of stock options (in shares)   (67)    
Common stock surrendered for the exercise of stock options (650)   (650)  
Net income $ 1,461     1,461
Ending Balance (in shares) at Sep. 30, 2023 13,950 13,950    
Ending Balance at Sep. 30, 2023 $ 102,439 $ 14 99,974 2,451
Expense related to director restricted stock units 618   618  
Expense related to employee stock-based compensation 1,280   1,280  
Stock issued for director restricted stock units (in shares)   62    
Stock issued for director restricted stock units $ 0      
Exercise of stock options (shares) 760 760    
Exercise of stock options $ 261   261  
Common stock surrendered for the exercise of stock options (in shares)   (381)    
Common stock surrendered for the exercise of stock options (1,863)   (1,863)  
Net income $ 7,397     7,397
Ending Balance (in shares) at Sep. 30, 2024 14,391 14,391    
Ending Balance at Sep. 30, 2024 $ 110,132 $ 14 $ 100,270 $ 9,848